A5010289373- Cutaneous Melanoma Detection and Management
- Psoriasis: Treatment and Pathogenesis
- Contact Dermatitis and Allergies
- Dermatology and Skin Diseases
- Telemedicine and Telehealth Implementation
- Autoimmune Bullous Skin Diseases
- AI in cancer detection
- Drug-Induced Adverse Reactions
- Mobile Health and mHealth Applications
- COVID-19 and healthcare impacts
- Allergic Rhinitis and Sensitization
- Healthcare Systems and Technology
- Electronic Health Records Systems
- Nonmelanoma Skin Cancer Studies
- Health Sciences Research and Education
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Food Allergy and Anaphylaxis Research
- Digital Imaging in Medicine
- Health Literacy and Information Accessibility
- Skin and Cellular Biology Research
- Patient Satisfaction in Healthcare
- Systemic Sclerosis and Related Diseases
- Asthma and respiratory diseases
- Fibromyalgia and Chronic Fatigue Syndrome Research
Stanford University
2021-2025
Monash Health
2023-2024
Monash University
2011-2024
National Cancer Centre Japan
2023
The University of Melbourne
2023
Women's College Hospital
2020-2023
Stanford Medicine
2022-2023
Association for the Advancement of Artificial Intelligence
2023
Austin Health
2023
University of Toronto
2017-2020
An estimated 3 billion people lack access to dermatological care globally. Artificial intelligence (AI) may aid in triaging skin diseases and identifying malignancies. However, most AI models have not been assessed on images of diverse tones or uncommon diseases. Thus, we created the Diverse Dermatology Images (DDI) dataset-the first publicly available, expertly curated, pathologically confirmed image dataset with tones. We show that state-of-the-art dermatology exhibit substantial...
Objectives To evaluate the uptake of a platform for virtual visits in primary care, examine patient and physician preferences communication methods report on characteristics patients experience care. Design A retrospective cohort study. Setting Primary care practices within five regions Ontario, Canada after 18 months access to services. Participants 326 providers 14 291 registered patients. Interventions Providers used that allowed them connect with their through synchronous (audio/video)...
Critically ill patients are vulnerable to penicillin allergy labels that may be incorrect. The validity of skin testing in intensive care units (ICUs) is uncertain. Many low risk, and validated tools exist identify those amenable direct oral challenge. This pilot randomised controlled trial explored the feasibility, safety, enteral challenge for low-risk critical illness. Consenting with a label (PAL) (PEN-FAST risk assessment score < 3) four ICUs (Melbourne, Australia) were 1:1 (250 mg...
Telemedicine use accelerated during the COVID-19 pandemic, and skin conditions were a common case. However, many images submitted may be of insufficient quality for making clinical determination.
Cite this as: J. M. Davies, T. D. Dang, A. Voskamp, C. Drew, Biondo, Phung, W. Upham, Rolland and R. E. O'Hehir, Clinical & Experimental Allergy, 2011 (41) 281–291. Summary Background Grass pollens are major triggers of allergic rhinitis asthma, but the immunological relationships between pollen allergens subtropical Bahia grass, Paspalum notatum , temperate grasses unresolved. Objective To assess serum IgE cross‐reactivity P. Lolium perenne (Ryegrass) allergens. Methods Serum...
ObjectiveTo understand and highlight the differences in clinical, demographic, image quality characteristics between patient-taken (PAT) clinic-taken (CLIN) photographs of skin conditions.Patients MethodsThis retrospective study applied logistic regression to data from 2500 deidentified cases Stanford Health Care's eConsult system, November 2015 January 2021. Cases with undiagnosable or multiple conditions both patient clinician sources were excluded, leaving 628 PAT 1719 CLIN cases....
To explore primary care physician (PCP) perspectives on the clinical utility of virtual visits.Qualitative design involving semistructured interviews.Primary practices within 5 regions in southern Ontario.Primary physicians representing different practice sizes and remuneration models.Interviews were conducted with PCPs who involved a large-scale pilot implementation visits (patient-provider asynchronous messaging, or synchronous audio video communication). The first phase convenience sample...
Secukinumab is an interleukin-17A monoclonal antibody approved in 2015 Canada and the United States for treatment of moderate-to-severe psoriasis adult patients.1,2 The current dosing regimen 300 mg subcutaneous at weeks 0, 1, 2, 3, 4, followed by monthly maintenance starting week 8.3 In clinical practice, some patients only partially respond to this schedule or display disease relapse during interim between injections. Some clinicians treat these using off-label secukinumab regimens, which...
Background: Current knowledge of the efficacy and safety ixekizumab is limited to data from phase III randomized controlled trials (RCTs). A gap exists in our understanding treatment outcomes this newly available biologic real-world clinical practice. Objective: This study explores non-RCT patients compare those reported RCTs. Methods: We conducted a multicentre, retrospective chart review treated with therapy for moderate-to-severe plaque psoriasis. Efficacy (Psoriasis Area Severity Index...
<p> </p> <p><strong>Objectives</strong> To evaluate the uptake of a platform for virtual visits in primary care, examine patient and physician preferences communication methods report on characteristics patients experience care.</p> <p><strong>Design</strong> A retrospective cohort study.</p> <p><strong>Setting</strong> Primary care practices within five regions Ontario, Canada after 18 months access to...
Secukinumab is an anti-IL-17A monoclonal antibody approved for the treatment of moderate-to-severe psoriasis in adult patients. Despite its favourable safety and efficacy profile clinical trials, some patients practice fail to respond adequately maintenance regimen 300 mg subcutaneous monthly. Some clinicians manage these by using off-label high-dose secukinumab regimens, which include shortening dosing interval every 2 or 3 weeks instead monthly, increasing monthly dose 450 mg.This study...
Abstract With an estimated 3 billion people globally lacking access to dermatological care, technological solutions leveraging artificial intelligence (AI) have been proposed improve 1 . Diagnostic AI algorithms, however, require high-quality datasets allow development and testing, particularly those that enable evaluation of both unimodal multimodal approaches. Currently, the majority dermatology algorithms are built tested on proprietary, siloed data, often from a single site with only...
To understand the impact of virtual visits on primary care physician (PCP) work flows.
Self-reported penicillin allergies are highly prevalent in hospitalised patients and associated with poor health service outcomes. Critically ill have historically been underrepresented prospective delabelling studies part due to concerns around clinical stability reliability of skin testing. Allergy assessment tools exist identify low-risk allergy phenotypes facilitate direct oral challenge delabelling. PEN-FAST is a decision rule that has validated predict true cohort non-critically...